QuidelOrtho Corp (QDEL)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$2.73B$2.78B$3.00B$3.27B$1.70B$1.66B
Research & development$186.2M$218.7M$245.0M$187.9M$95.7M$84.3M
Operating income−$919.2M−$1.96B$139.1M$843.7M$906.0M$1.06B
EBITDAderived−$477.2M−$1.51B$596.3M$1.13B$958.7M$1.11B
Net income−$1.13B−$2.05B−$10.1M$548.7M$704.2M$810.3M
Basic EPSper diluted share-$16.69-$30.54-$0.15$9.66$16.74$19.24
Diluted EPSper diluted share-$16.69-$30.54-$0.15$9.56$16.43$18.60

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys10$1.58M disclosed value
Sells (SEC code S)80$416.76M disclosed value
90 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Feb 13, 2026Form 4/ABusky Joseph M.Chief Financial OfficerBuyCommon Stock · indirect3.4K$23.66$79.7K10.3K
Feb 13, 2026Form 4Blaser Brian J.President and CEOBuyCommon Stock · indirect10.5K$23.59$248.6K40.1K
Feb 13, 2026Form 4Busky Joseph M.Chief Financial OfficerBuyCommon Stock · indirect3.4K$23.66$79.7K10.3K
Feb 13, 2026Form 4Strobeck MatthewDirectorBuyCommon Stock10.0K$23.96$239.6K27.8K
Dec 10, 2025Form 4RHOADS ANN DDirectorBuyCommon Stock750$28.28$21.2K15.0K